Kevin T. Love: h-index, Total Citations, and Citation Map
Kevin T. Love's h-index is 27 (36 i10-index, 9,371+ total citations across 5+ publications) according to Google Scholar as of May 2026. Kevin T. Love is affiliated with Unknown affiliation.
Kevin T. Love is a researcher affiliated with Unknown affiliation, specializing in Nucleic acid delivery, RNAi, Vaccines. Their work has been cited 9,371 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Kevin T. Love's Citation Metrics
Bibliometric impact based on 5 indexed publications.
- H-Index
- 27
- i10-Index
- 36
- Total Citations
- 9,371
- Citing Countries
- 6
As of May 2026.
Kevin T. Love has an h-index of 27 and 9,371 total citations across 5 publications, with research cited by institutions in 6 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Kevin T. Love's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 9,371 citations for Kevin T. Love
We've shown the most-cited 5,000. Unlock the full crawl (9,356 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Top Cited Works
Tip: clickto hide a row from the map
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
20121,350
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher developed lipid-like materials enabling low-dose, in vivo gene silencing, a foundational advance in non-viral delivery systems evidenced by over 1,200 citations.
The researcher developed molecularly self-assembled nucleic acid nanoparticles to enable targeted in vivo siRNA delivery, establishing a foundational platform for gene silencing therapeutics.
The researcher pioneered therapeutic siRNA silencing in inflammatory monocytes, establishing a foundational model for targeted gene therapy in murine immune cells.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
